Clinical studies recruiting near Morgantown

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
Phase 3 · West Virginia University · Harmony Biosciences Management, Inc. · NCT07500090 Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Phase N/A · Galderma Investigational Site 8725 · Galderma R&D · NCT06988605 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · West Virginia University Healthcare · National Cancer Institute (NCI) · NCT06172296 A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Phase 3 · Frontier Clinical Research · Kallyope Inc. · NCT07674654 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · West Virginia University Healthcare · NRG Oncology · NCT05624996 NIMH Clinical Pathway in Rural Appalachian School-based Health Clinics
NA · West Virginia University · West Virginia University · NCT06808503 PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · West Virginia University Medicine · Boehringer Ingelheim · NCT07355296 Treatment With Endovascular Intervention for STroke Patients With Existing Disability
Phase N/A · West Virginia University · University of Cincinnati · NCT05911568 Cigar Legislation and Regulation in Tobacco for the Young (Project CLARITY)
NA · West Virginia University · University of Oklahoma · NCT07162935 Registry for Stage 2 Type 1 Diabetes
Phase N/A · United BioSource Corporation- Site Number : 8400001 · Sanofi · NCT06481904 A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic
Phase 3 · Research Site · AstraZeneca · NCT06868277 Low-Intensity Focused Ultrasound (LIFU) Neuromodulation
NA · Rockefeller Neuroscience Institute at West Virginia Universi · Ali Rezai · NCT05997030 A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Phase 2 · West Virginia University Health Sciences Campus · Fore Biotherapeutics · NCT05503797 Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts
Phase N/A · West Virginia University · Vesalio · NCT06893588 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · West Virginia University Healthcare · NRG Oncology · NCT05946213 Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Ca
Phase N/A · West Virginia University Hospital · Duke University · NCT04278404 Leflunomide in Combination With Decitabine for Treatment of Relapsed or Refractory Myelodysplastic Syndromes
Phase 1/Phase 2 · West Virginia University Cancer Institute · West Virginia University · NCT06923488 A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in Fi
Phase 3 · West Virginia University Health Sciences Center · Amgen · NCT07005128 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosc
Phase 3 · West Virginia University Medicine · Boehringer Ingelheim · NCT07220083 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · West Virginia University Healthcare · NRG Oncology · NCT05174169 Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome
Phase 3 · WVU Medicine Children's Hospital · Aerogen Pharma Limited · NCT06776783 Actinic Keratoses Treated With 5-fluorouracil Plus Aluminum
Phase 1 · West Virginia University · West Virginia University · NCT07401277 A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes
Phase N/A · WVU Hospitals · Bristol-Myers Squibb · NCT05489705 A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Phase 3 · West Virginia University · Takeda · NCT06963827 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Mo
Phase 2 · Study Site 005 · ReAlta Life Sciences, Inc. · NCT05778188 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · West Virginia University Healthcare · Alliance for Clinical Trials in Oncology · NCT06876714 A Global Pregnancy Registry to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to YORVIPATH® (Palopegteri
Phase N/A · Ascendis Investigational Site · Ascendis Pharma A/S · NCT07345494 Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
Phase 2 · West Virginia University Hospitals /ID# 256841 · AbbVie · NCT03339128 Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusi
Phase N/A · West Virginia University · Bayer · NCT04142437 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557

Look up another city

Look up another condition